nialamide has been researched along with Obesity in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CHAPUY, P | 1 |
| MALLURET, J | 1 |
| PLAUCHU, M | 1 |
| Lernmark, A | 1 |
2 other studies available for nialamide and Obesity
| Article | Year |
|---|---|
[APROPOS OF THE UTILIZATION OF MONOAMINE OXIDASE INHIBITOR IN GENERAL MEDICINE].
Topics: Biomedical Research; Cardiovascular Diseases; Depression; Depressive Disorder; Drug Therapy; Geriatr | 1964 |
The significance of 5-hydroxytryptamine for insulin secretion in the mouse.
Topics: 5-Hydroxytryptophan; Animals; Bromine; Drug Antagonism; Glucose; Hyperglycemia; In Vitro Techniques; | 1971 |